• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,2,3-二噻唑类化合物对谷氨酰胺/氨基酸转运蛋白 ASCT2 的抑制作用:用于深入了解作用机制和抗肿瘤活性的质体。

Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity.

机构信息

Dipartimento di Biologia Cellulare Università della Calabria, via P. Bucci 4 c, 87036 Arcavacata di Rende (CS), Italy.

出版信息

Toxicol Appl Pharmacol. 2012 Nov 15;265(1):93-102. doi: 10.1016/j.taap.2012.09.011. Epub 2012 Sep 23.

DOI:10.1016/j.taap.2012.09.011
PMID:23010140
Abstract

The ASCT2 transport system catalyses a sodium-dependent antiport of glutamine and other neutral amino acids which is involved in amino acid metabolism. A library of 1,2,3-dithiazoles was designed, synthesized and evaluated as inhibitors of the glutamine/amino acid ASCT2 transporter in the model system of proteoliposomes reconstituted with the rat liver transporter. Fifteen of the tested compounds at concentration of 20μM or below, inhibited more than 50% the glutamine/glutamine antiport catalysed by the reconstituted transporter. These good inhibitors bear a phenyl ring with electron withdrawing substituents. The inhibition was reversed by 1,4-dithioerythritol indicating that the effect was likely owed to the formation of mixed sulfides with the protein's Cys residue(s). A dose-response analysis of the most active compounds gave IC(50) values in the range of 3-30μM. Kinetic inhibition studies indicated a non-competitive inhibition, presumably because of a potential covalent interaction of the dithiazoles with cysteine thiol groups that are not located at the substrate binding site. Indeed, computational studies using a homology structural model of ASCT2 transporter, suggested as possible binding targets, Cys-207 or Cys-210, that belong to the CXXC motif of the protein.

摘要

ASCT2 转运系统催化谷氨酰胺和其他中性氨基酸的钠依赖性反向转运,这涉及氨基酸代谢。设计、合成并评估了 1,2,3-二噻唑库作为谷氨酸盐/氨基酸 ASCT2 转运蛋白在与大鼠肝转运蛋白重建的蛋白脂质体模型系统中的抑制剂。在浓度为 20μM 或以下的 15 种测试化合物中,有 15 种化合物抑制了由重建的转运蛋白催化的谷氨酰胺/谷氨酰胺反向转运超过 50%。这些良好的抑制剂带有带吸电子取代基的苯环。1,4-二硫赤藓糖醇的反转表明,这种效果可能归因于与蛋白质半胱氨酸残基(s)形成混合硫化物。最活跃的化合物的剂量反应分析给出了 3-30μM 的 IC50 值。动力学抑制研究表明非竞争性抑制,可能是由于二噻唑与半胱氨酸巯基的潜在共价相互作用,而这些巯基不在底物结合位点处。实际上,使用 ASCT2 转运蛋白的同源结构模型进行的计算研究表明,Cys-207 或 Cys-210 可能是可能的结合靶标,它们属于蛋白质的CXXC 基序。

相似文献

1
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity.1,2,3-二噻唑类化合物对谷氨酰胺/氨基酸转运蛋白 ASCT2 的抑制作用:用于深入了解作用机制和抗肿瘤活性的质体。
Toxicol Appl Pharmacol. 2012 Nov 15;265(1):93-102. doi: 10.1016/j.taap.2012.09.011. Epub 2012 Sep 23.
2
Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling.汞离子和甲基汞对脂质体重建的谷氨酰胺/氨基酸转运蛋白(ASCT2)的失活作用:通过同源建模预测CXXC 基序的参与。
Biochem Pharmacol. 2010 Oct 15;80(8):1266-73. doi: 10.1016/j.bcp.2010.06.032. Epub 2010 Jul 1.
3
Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris--functional and kinetic asymmetry revealed in proteoliposomes.在毕赤酵母中大规模生产活性人ASCT2(SLC1A5)转运蛋白——蛋白脂质体中揭示的功能和动力学不对称性
Biochim Biophys Acta. 2013 Sep;1828(9):2238-46. doi: 10.1016/j.bbamem.2013.05.034. Epub 2013 Jun 10.
4
Reconstitution into liposomes of the glutamine/amino acid transporter from renal cell plasma membrane: functional characterization, kinetics and activation by nucleotides.肾细胞质膜谷氨酰胺/氨基酸转运体在脂质体中的重组:功能特性、动力学及核苷酸激活作用
Biochim Biophys Acta. 2004 Dec 15;1667(2):122-31. doi: 10.1016/j.bbamem.2004.09.007.
5
Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter.半胱氨酸不是人ASCT2(SLC1A5)转运蛋白的底物,而是一种特异性调节剂。
FEBS Lett. 2015 Nov 30;589(23):3617-23. doi: 10.1016/j.febslet.2015.10.011. Epub 2015 Oct 19.
6
The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: electrical nature of the glutamine/glutamate antiport.脂质体中重组的谷氨酰胺/氨基酸转运体(ASCT2):谷氨酰胺/谷氨酸反向转运的电特性
Ital J Biochem. 2007 Dec;56(4):275-8.
7
The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: transport mechanism, regulation by ATP and characterization of the glutamine/glutamate antiport.脂质体中重组的谷氨酰胺/氨基酸转运体(ASCT2):转运机制、ATP调节及谷氨酰胺/谷氨酸反向转运的特性
Biochim Biophys Acta. 2007 Feb;1768(2):291-8. doi: 10.1016/j.bbamem.2006.09.002. Epub 2006 Sep 16.
8
Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport.Cys 定点突变的人 SLC1A5(ASCT2)转运体:结构/功能关系和 Cys467 对半胱氨酸还原感应和谷氨酰胺转运的关键作用。
Int J Mol Sci. 2018 Feb 25;19(3):648. doi: 10.3390/ijms19030648.
9
Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism.天冬氨酸/丝氨酸协同转运蛋白 2 氨基酸转运体的 Cys467 是其协同转运机制的分子决定因素。
Int J Mol Sci. 2022 Jan 20;23(3):1127. doi: 10.3390/ijms23031127.
10
Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.基于磺胺和磺酸酯骨架的新型丙氨酰-丝氨酰-半胱氨酸转运蛋白 2(ASCT2)抑制剂。
J Gen Physiol. 2019 Mar 4;151(3):357-368. doi: 10.1085/jgp.201812276. Epub 2019 Feb 4.

引用本文的文献

1
Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake.芫花酯甲通过促进ASCT2降解和抑制谷氨酰胺摄取来抑制头颈癌生长。
Acta Pharmacol Sin. 2025 May 15. doi: 10.1038/s41401-025-01562-2.
2
Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches.探索氨基酸转运体作为癌症治疗靶点:抑制剂结构、选择性问题及发现方法研究
Pharmaceutics. 2024 Jan 30;16(2):197. doi: 10.3390/pharmaceutics16020197.
3
Glutaminolysis and peripheral CD4 T cell differentiation: from mechanism to intervention strategy.
谷氨酰胺分解代谢与外周 CD4 T 细胞分化:从机制到干预策略。
Front Immunol. 2023 Jul 21;14:1221530. doi: 10.3389/fimmu.2023.1221530. eCollection 2023.
4
The Synthesis and Biological Applications of the 1,2,3-Dithiazole Scaffold.1,2,3-二噻唑骨架的合成及生物应用。
Molecules. 2023 Apr 3;28(7):3193. doi: 10.3390/molecules28073193.
5
Synthesis of 2-Cyanobenzothiazoles via Pd-Catalyzed/Cu-Assisted C-H Functionalization/Intramolecular C-S Bond Formation from -Arylcyanothioformamides.通过 Pd 催化/Cu 辅助的 C-H 功能化/分子内 C-S 键形成,从 -芳基氰硫代甲酰胺合成 2-氰基苯并噻唑。
Molecules. 2022 Dec 1;27(23):8426. doi: 10.3390/molecules27238426.
6
Computational Study Reveals the Role of Water Molecules in the Inhibition Mechanism of LAT1 by 1,2,3-Dithiazoles.计算研究揭示了 1,2,3-二噻唑类化合物抑制 LAT1 的抑制机制中水分子的作用。
J Chem Inf Model. 2021 Dec 27;61(12):5883-5892. doi: 10.1021/acs.jcim.1c01012. Epub 2021 Nov 17.
7
Crystal Structure and Solid-State Packing of 4-Chloro-5-1,2,3-dithiazol-5-one and 4-Chloro-5-1,2,3-dithiazole-5-thione.4-氯-5-1,2,3-二噻唑-5-酮和 4-氯-5-1,2,3-二噻唑-5-硫酮的晶体结构和固态包装。
Molecules. 2021 Sep 28;26(19):5875. doi: 10.3390/molecules26195875.
8
The role of the glutamine transporter ASCT2 in antineoplastic therapy.谷氨酸盐转运蛋白 ASCT2 在抗肿瘤治疗中的作用。
Cancer Chemother Pharmacol. 2021 Apr;87(4):447-464. doi: 10.1007/s00280-020-04218-6. Epub 2021 Jan 19.
9
Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How.氨基酸转运蛋白作为癌症治疗的靶点:原因、位置、时机和方式。
Int J Mol Sci. 2020 Aug 26;21(17):6156. doi: 10.3390/ijms21176156.
10
Synthesis of 2-((2-(Benzo[d]oxazol-2-yl)-2-imidazol-4-yl)amino)-phenols from 2-((5-1,2,3-Dithiazol-5-ylidene)amino)phenols through Unprecedented Formation of Imidazole Ring from Two Methanimino Groups.从 2-((5-1,2,3-二噻唑-5-基亚氨基)氨基)苯酚通过两个亚甲氨基形成咪唑环合成 2-((2-(苯并[d]恶唑-2-基)-2-咪唑基)氨基)苯酚
Molecules. 2020 Aug 19;25(17):3768. doi: 10.3390/molecules25173768.